Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 112

Ventus Therapeutics executes $100m series B

GV returned to reinvest in small molecule drug developer Ventus Therapeutics having backed its $60m series A round almost a year ago.

Apr 9, 2021

Plaid plays on to $425m series D

Altimeter Capital has led a round for the Alphabet, Amex, Citi, Mastercard and Visa-backed financial data sharing service, valuing it at $13.4bn.

Apr 8, 2021

Kavak drives through $485m series D round

The SoftBank-backed used car marketplace more than tripled its valuation to $4bn in seven months, with D1 Capital Partners leading the round.

Apr 8, 2021

Icosavax racks up $100m

RA Capital Management has led a series B round for the UW-linked vaccine developer, which had raised $51m in a series A 18 months ago.

Apr 8, 2021

Oda drops Kolonial past to raise $265m

Prosus and SoftBank Vision Fund 2 co-led a round valuing the the online grocery retailer, which has just rebranded, at $900m post-money.

Apr 8, 2021

Icosavax racks up $100m

Sanofi Ventures reinvested in the vaccine developer through a series B round that followed a $51m series A 18 months ago.

Apr 8, 2021

Redis Labs logs $110m in series G

The database software provider completed a series G round backed by SoftBank Vision Fund 2 at a valuation exceeding $2bn.

Apr 8, 2021

Phenom finds $100m for series D round

The Axa-backed talent recruitment platform developer has secured funding in a series D round led by B Capital Group at a $1.3bn valuation.

Apr 8, 2021

Innostar shines in pre-series A round

The Lam Research-backed storage chip developer has raised about $100m in a round led by another earlier investor, Shanghai Lianhe Investment.

Apr 8, 2021

PharmEasy fits Prosus into $350m round

The online pharmacy is set to close a round co-led by Prosus Ventures at a $1.5bn post-money valuation, taking its overall funding past $670m.

Apr 7, 2021
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here